Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ — The Association for the Accreditation of Human Research Protection Continue Reading
Exyte demonstrates high-potential digital Smart Fab Solution at SEMICON China 2019
SHANGHAI, March 22, 2019 /PRNewswire/ — Exyte, the global leader in the design, engineering and construction of high-tech facilities, plants and factories, showcases its Smart Continue Reading
Equipping “Good Village Doctors” with AI technology
-Ping An Good Doctor Utilize Advanced Technology to Achieve Health and Poverty Alleviation BEIJING, March 21, 2019 /PRNewswire/ — The ceremony of “Village Warming with Blossom — Continue Reading
Merck Opens First M Lab™ Collaboration Center in Europe
– Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment – Hands-on customer access to Merck’s Life Science Continue Reading
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019
New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023 Game-changing therapies addressing immune-related and genetic Continue Reading
Concord Medical Announces New Appointments to Management Team
BEIJING, March 19, 2019 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solutions provider Continue Reading
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
– License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration.– OliX Continue Reading
CSPC Pharmaceutical Announces 2018 Annual Results
Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ Continue Reading
Adlai Nortye’s Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC
NORTH BRUNSWICK, N.J., March 15, 2019 /PRNewswire/ — Adlai Nortye Ltd. (“Adlai Nortye”), a global clinical-stage biopharmaceutical company today released the animal model data of Buparlisib Continue Reading
Dornier MedTech Announces Dornier OptiVision Next-Generation Digital Image Processing Technology for Stone Treatment and Day-to-Day Endourology
MUNICH, March 15, 2019 /PRNewswire/ — Dornier MedTech (Dornier), the global leader in stone management that pioneered Extracorporeal Shockwave Lithotripter (ESWL) technology, today announced that Continue Reading